IHS Holding Limited (IHS) Q4 Revenue Tops Consensus
Get Alerts IHS Hot Sheet
Price: $8.31 -0.24%
EPS Growth %: -65.9%
Financial Fact:
Total revenue: 587.97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
EPS Growth %: -65.9%
Financial Fact:
Total revenue: 587.97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
IHS Holding Limited (NYSE: IHS) reported Q4 EPS of ($0.82), $0.79 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $526.2 million versus the consensus estimate of $486.85 million.
GUIDANCE:
IHS Holding Limited sees FY2023 revenue of $2.19-2.22 billion, versus the consensus of $2.09 billion.
- Adjusted EBITDA of $1,200-$1,220 million, RLFCF of $430-450 million, Total Capex of $610-650 million and net leverage ratio target remains 3.0x-4.0x
For earnings history and earnings-related data on IHS Holding Limited (IHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share